Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study.

Breast Cancer Res Treat · 2021 · PMC8557195 · PMID 34460030

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

For breast cancer-specific mortality, breast cancer cases who reported having ever versus never used cholesterol lowering drugs had a 17% lowered hazard of mortality (HR 0.83, 95% CI 0.49–1.39, Supplementary Table 2) that did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.